News
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
Shares of WW International, formerly known as Weight Watchers, more than doubled after the company received a letter from an activist investor arguing against a Chapter 11 bankruptcy filing. The ...
A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.
The New England Journal of Medicine received a letter suggesting that it was biased and compromised by external pressure.
Dr William Li, whose book Eat to Beat Your Diet is a New York Times bestseller, says the most dangerous type of fat is ...
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...
Social media has fueled a “proteinification” of snacks, and Khloé Kardashian is hopping on board with a line of enhanced ...
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
People are dying to lose weight,' the study's authors have warned.
Pop star Lizzo recently revealed her weight loss journey. She lost 16 percent of her body fat through calorie deficit and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results